T Cells & B Cells — T cells and B cells (overview)

Historical Context & Motivation

The modern understanding of adaptive immunity rests upon a century of experiments that gradually revealed the existence of two distinct lymphocyte lineages. Before scientists identified T cells and B cells, the prevailing view held that white blood cells were a relatively homogeneous population that combatted infection through phagocytosis alone. The discovery that lymphocytes could be divided into functionally and developmentally separate compartments—one responsible for cell-mediated immunity and the other for humoral immunity—transformed immunology from a descriptive discipline into a mechanistic science with profound clinical implications.

These discoveries raised a central question that continues to drive immunological research: how do T cells and B cells, arising from the same hematopoietic stem cell, diverge so dramatically in their receptor systems, effector functions, and regulatory roles—and how does their cooperation generate the specificity, diversity, and immunological memory that define adaptive immunity?

Core Principles & Definitions

Both T cells and B cells are lymphocytes—a category of white blood cell that participates in the adaptive arm of the immune system. Despite sharing a common origin in the bone marrow's hematopoietic stem cells, these two populations differentiate in distinct anatomical compartments, express unique antigen receptors, and execute complementary effector programs. Understanding their shared and divergent properties requires grasping several foundational principles.

Visual Overview — Lymphocyte Development & Function

The diagram above encapsulates the central organizational logic of adaptive immunity. Notice that the divergence point is anatomical: the thymus sculpts T cell repertoires through a stringent two-stage selection process, while the bone marrow accomplishes an analogous screening for B cells. The dashed line between T helper cells and the B cell branch represents the critical cognate interaction—most B cell responses to protein antigens are T-dependent, meaning class switching and affinity maturation require signals delivered by CD4⁺ T cells in germinal centers.

Mechanisms of Antigen Recognition

The most fundamental distinction between T cells and B cells lies in how they recognize antigen. B cells express the B cell receptor (BCR), which is a membrane-bound immunoglobulin capable of binding intact, native antigen—proteins, carbohydrates, lipids, and even small chemical haptens—in three-dimensional conformation. T cells, on the other hand, express the T cell receptor (TCR), which can only recognize short peptide fragments presented in the groove of major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells or target cells. This MHC restriction is the hallmark of T cell biology.

BCR vs. TCR Structure

The BCR consists of a membrane-bound immunoglobulin (mIg) molecule—typically IgM or IgD on naïve B cells—non-covalently associated with the signaling heterodimer Igα/Igβ (CD79a/CD79b). The mIg provides antigen specificity through its variable regions (V_H and V_L), while Igα/Igβ contain immunoreceptor tyrosine-based activation motifs (ITAMs) that transduce signals into the cell upon antigen crosslinking. The TCR, by contrast, is a heterodimer of α and β chains (or γ and δ chains in a minor subset), each containing one variable and one constant domain. Like the BCR, the TCR relies on associated signaling modules—the CD3 complex (γε, δε, and ζζ dimers)—to initiate intracellular signaling cascades through their ITAMs.

MHC Class I vs. Class II Restriction

The co-receptor expressed by a T cell determines which class of MHC molecule it surveys. CD8⁺ cytotoxic T lymphocytes (CTLs) recognize peptides presented by MHC class I molecules, which are expressed on nearly all nucleated cells and typically present endogenously synthesized peptides—including viral proteins and tumor antigens. CD4⁺ T helper (T_H) cells recognize peptides displayed by MHC class II molecules, which have a more restricted tissue distribution—primarily expressed on professional antigen-presenting cells such as dendritic cells, macrophages, and B cells—and present exogenous, phagocytosed antigens.

T Cell and B Cell Subsets in Detail

The terms 'T cell' and 'B cell' each encompass a family of functionally distinct subsets. Appreciating this diversity is essential because different subsets are activated by different cytokine milieus, express different transcription factors, and execute different effector programs. Clinical pathologies—from immunodeficiencies to autoimmune diseases—often map to the dysfunction of a specific subset rather than a wholesale failure of an entire lineage.

Major T Cell Subsets

Major B Cell Subsets

Worked Example — Tracing an Immune Response

To integrate T cell and B cell biology, let us trace the adaptive immune response to a hypothetical intramuscular injection of an inactivated influenza vaccine containing hemagglutinin (HA) protein antigen.

T Cells vs. B Cells — Side-by-Side Comparison

While T cells and B cells are both lymphocytes with somatically rearranged antigen receptors, their differences in development, receptor structure, antigen recognition, and effector output are profound. The following table consolidates the major distinguishing features to serve as a reference for comparison.

Connection to Advanced Immunology

The overview of T and B cell biology presented here serves as a foundation for several advanced topics that are the focus of current immunological research and clinical translation. Understanding these connections provides a roadmap for deeper study.

One of the most transformative clinical applications arising from T and B cell biology is CAR-T cell therapy, in which a patient's own T cells are genetically engineered ex vivo to express a chimeric antigen receptor—typically an antibody-derived single-chain variable fragment (scFv) fused to intracellular T cell signaling domains. This construct effectively gives a T cell the antigen-binding specificity of an antibody (B cell heritage) combined with the cytotoxic machinery of a CTL (T cell heritage), creating a hybrid weapon that bypasses the need for MHC presentation entirely. Success in treating relapsed B cell acute lymphoblastic leukemia highlights how a deep understanding of both lineages enables innovative therapeutic design.

Practice Problems

Lesson Summary